Kindlin and EGFR control convergent pathways to regulate epithelial cell function
Kindlin and EGFR control convergent pathways to regulate epithelial cell function
批准号:
MR/M018512/1
负责人:
Madeline Parsons
金额:
$93.77万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This research relates to two proteins that we know are not correctly controlled in patients with skin blistering disease. These proteins are called Kindlin-1 and Epidermal Growth Factor Receptor (or EGFR). We already know that lack of Kindlin-1 in the skin leads to Kindler Syndrome - a rare genetic disorder that results in skin blistering and sometimes leads to skin cancer. We have also recently identified a new group of patients that have defective EGFR protein and this similarly results in fragile skin. Our recent research on these two proteins strongly suggests that the observed clinical defects in the patients are partly caused by similar processes going wrong. This defect is mainly in the ability of cells to stick, or 'adhere' to the proteins that surround them in the skin. Normal functioning of the adhesion process is critical to health, and if it goes wrong, the sort of diseases that might occur include skin fragility, psoriasis, cancer, reduced immunity and inflammation. The research we would like to do now involves analysing Kindlin-1 and EGFR function in more detail. We firstly want to know precisely how these proteins work together to contribute to normal skin function. We plan to use a number of biochemical and microscopy techniques to answer questions such as: do these two proteins bind together in cells; how does loss of one or the other upset the ability of cells to adhere to proteins around them, and how do the common 'targets' of this protein complex also control this process? In our research we would also like to create more complex models to allow us to study Kindlin-1 and EGFR function in an intact organism. The reason we want to do this is because we would like to find out how these proteins behave in a more 'real' setting where there are other cells and tissues that might alter how these proteins behave. We will use a very well characterized model of epidermal blistering in the Fruitfly for this purpose. These animals are much easier, cheaper and faster to work with than mice and have versions of all of the genes/proteins we are planning to study, so are ideal for our experiments. By combining the information we get from experiments in cells, human tissues and the Fruitfly model, we can also start to plan potential corrective treatments with genes, proteins and drugs, work that could lead to improvements for patients in the future. Such work could lead to less skin blistering and improved quality of life in this and other families that have defects in Kindlin-1 or EGFR. The work is expected to expand our knowledge of the fundamentally important basic science topic of cell adhesion to surrounding tissues as well as the physiological maintenance of healthy skin.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Coagulation Factor XIII-A Subunit Missense Mutation in the Pathobiology of Autosomal Dominant Multiple Dermatofibromas.
常染色体显性多发性皮肤纤维瘤病理学中的凝血因子 XIII-A 亚基错义突变。
DOI:
10.1016/j.jid.2019.08.441
发表时间:
2020
期刊:
The Journal of investigative dermatology
影响因子:
--
作者:
[Supsrisunjai C]
通讯作者:
Supsrisunjai C
Measurement of Mechanical Tension at cell-cell junctions using two-photon laser ablation
使用双光子激光烧蚀测量细胞与细胞连接处的机械张力
DOI:
10.21769/bioprotoc.2068
发表时间:
2016
期刊:
BIO-PROTOCOL
影响因子:
0.8
作者:
[Liang X]
通讯作者:
Liang X
Analysis of Myosin II Minifilament Orientation at Epithelial Zonula Adherens.
上皮粘附小带肌球蛋白 II 微丝方向的分析。
DOI:
10.21769/bioprotoc.2054
发表时间:
2016
期刊:
Bio-protocol
影响因子:
0.8
作者:
[Michael M]
通讯作者:
Michael M
23-BIUK - Strategic funding for BioImagingUK
-
批准号:BB/Z000017/1
-
项目类别:Research Grant
-
资助金额:$34.52万
-
财政年份:2024
-
负责人:Madeline Parsons
-
依托单位:
Multi-scale mechanochemical signals regulating cancer cell survival and invasive potential
-
批准号:MR/W024985/1
-
项目类别:Research Grant
-
资助金额:$235.39万
-
财政年份:2022
-
负责人:Madeline Parsons
-
依托单位:
BioImagingUK Community Network
-
批准号:BB/S018689/1
-
项目类别:Research Grant
-
资助金额:$15.52万
-
财政年份:2019
-
负责人:Madeline Parsons
-
依托单位:
Defining the role of CAR in lung homeostasis and response to inflammation
-
批准号:MR/S009191/1
-
项目类别:Research Grant
-
资助金额:$58.6万
-
财政年份:2019
-
负责人:Madeline Parsons
-
依托单位:
MICA: Control of tumour cell apoptosis by nuclear F-actin bundling
-
批准号:MR/R008264/1
-
项目类别:Research Grant
-
资助金额:$74.62万
-
财政年份:2018
-
负责人:Madeline Parsons
-
依托单位:
Integrative Biological Imaging Network (IBIN)
-
批准号:MR/R025665/1
-
项目类别:Research Grant
-
资助金额:$95.93万
-
财政年份:2018
-
负责人:Madeline Parsons
-
依托单位:
Fascin-dependent control of nuclear plasticity in invading cells
-
批准号:MR/J000647/1
-
项目类别:Research Grant
-
资助金额:$46.36万
-
财政年份:2012
-
负责人:Madeline Parsons
-
依托单位:
Integrin specificity regulating chemotaxis in 3-dimensional matrix.
-
批准号:BB/D016185/1
-
项目类别:Research Grant
-
资助金额:$37.05万
-
财政年份:2006
-
负责人:Madeline Parsons
-
依托单位:
国内基金
海外基金
登录
查看更多内容
间充质干细胞通过调控 CXCL16/CXCR6-EGFR-自噬轴缓解放射性直肠损伤纤维化的机制研究
-
批准号:2026JJ50608
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:屈展
-
依托单位:
新型喹唑啉酮类EGFR抑制剂设计、合成及抗肿瘤生物活性检测
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王静
-
依托单位:
OGT介导O-GlcNAc糖基化修饰SENP1调控EGFR去SUMO化促进结直肠癌对西妥昔单抗治疗耐药的机制研究
-
批准号:2026JJ81361
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周园
-
依托单位:
金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
-
批准号:2026JJ81256
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李弘德
-
依托单位:
EGFR/MAPK/ERK信号通路介导肿瘤相关成纤维细胞分泌TNC导致复发/转移头颈部鳞状细胞癌免疫治疗抵抗的机制研究
-
批准号:JCZRLH202600215
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
开心散调控EGFR/PI3K/AKT通路改善阿尔茨海默病神经元损伤的机制研究
-
批准号:JCZRLH202600463
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
P11-EGFR复合物调控在非小细胞肺癌靶向治疗耐药中的作用及分子机制
-
批准号:JCZRLH202600805
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于健康人uEVs RNA基线解析uEVs EPN1 mRNA通过调控EGFR内吞分选促进膀胱癌进展的机制研究
-
批准号:JCZRLH202600293
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HK2通过非酶促依赖抑制EGFR泛素化降解介导肺腺癌奥希替尼敏感性的机制研究
-
批准号:2026JJ80973
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘索
-
依托单位:
SGPL1通过招募PTK6上调EGFR磷酸化促进肺腺癌细胞增殖和迁移
-
批准号:2026JJ80579
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘朝晖
-
依托单位: